PulseCath Achieves MDR CE Certification for iVAC 2L, Paving the Way for Complex High-Risk Percutaneous Coronary Interventions

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

PulseCath-MDRCE-iVAC

More Like This

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

PR Newswire associated0

Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors

iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System

Business Wire logo

CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology

PR Newswire associated0

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

Business Wire embedded0

CroíValve Announces Funding from Horizon Europe EIC Accelerator

PR Newswire associated0

BIOTRONIK Expands Cardiac Rhythm Care by Launching World's First CRT-D Systems Approved for Conduction System Pacing

ACCESS Newswire logo

SafeHeal(R) Receives European Marketing Approval Under MDR for Colovac(R) Anastomosis Protection Technology